ProQR Therapeutics NV Stock Price - PRQR

-0.01 (-0.19%)
Upgrade to Real-Time
Afterhours (Closed)
Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
Small Cap Basic
Monthly Subscription
for only
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
ProQR Therapeutics NV PRQR NASDAQ Common Stock
  Price Change Change Percent Stock Price Low Price High Price Open Price Close Price Last Traded
-0.19 -3.49% 5.26 5.20 5.4957 5.43 5.45 20:00:00
Bid Price Ask Price Spread Spread % News
3.18 6.20 3.02 48.71% - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
1,082 75,180 $ 5.33 $ 400,417 157,832 4.46 - 13.28
Last Trade Time Type Quantity Stock Price Currency
16:58:10 8 $ 5.25 USD

ProQR Therapeutics NV Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 262.82M 49.97M 49.97M $ - $ - -1.55 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% - -

more financials information »

ProQR Therapeutics NV News

Date Time Source News Article
5/07/202007:32Edgar (US Regulatory)Report of Foreign Issuer (6-k)
3/31/202017:07Edgar (US Regulatory)Annual and Transition Report (foreign Private Issuer) (20-f)
3/31/202016:49Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)
3/31/202007:12Edgar (US Regulatory)Report of Foreign Issuer (6-k)
2/26/202007:53Edgar (US Regulatory)Report of Foreign Issuer (6-k)
2/14/202013:53Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)
2/12/202016:12Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical PRQR Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week5.,7190.183.54%
1 Month5.246.134.705.28152,0550.020.38%
3 Months6.758.694.465.76202,065-1.49-22.07%
6 Months8.0510.984.467.48234,888-2.79-34.66%
1 Year11.5313.284.467.78225,035-6.27-54.38%
3 Years5.0524.002.7511.14194,3460.214.16%
5 Years20.0124.002.7510.65141,595-14.75-73.71%

ProQR Therapeutics NV Description

ProQR Therapeutics NV is a biopharmaceutical company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber's congenital amaurosis type 10 and dyastrophic epidermolysis bullosa. The company's main product candidates are QR-010, QR-110, and QR-313. Its product pipeline includes QRX-704, QRX-504, QRX-421, QRX-323 etc.
Your Recent History
ProQR Ther..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20200525 02:27:41